KC-1265
Programmed death ligand 1 (PD-L1, CD274), also known as B7-H1, is a B7-family immune checkpoint ligand expressed on antigen-presenting cells, tumor cells and activated T cells. By engaging PD-1 it suppresses effector T-cell proliferation and cytokine production and maintains peripheral tolerance. Tumor upregulation of PD-L1 drives immune escape, and anti-PD-1/PD-L1 antibodies such as atezolizumab are established cancer immunotherapies.
| Catalog Number | KC-1265 |
|---|---|
| Cell Line Name | MC38-PDL1 Cell Line |
| NCBI/UniProt Accession Number | NM_014143.4 |
| Clone Number | 1# |
| Host Cell Line | MC38-XH |
| Description | The MC38-PDL1 cell line stably overexpresses human CD274 (PD-L1) |
| Quantity | One vial of frozen cells (≥2×106 cells) |
| Stability | Stable in culture over a minimum of 10 passages |
| Application | Drug screening and biological assays |
| Freezing Medium | 70% DMEM+20%FBS+10%DMSO |
| Propagation Medium | DMEM+10%FBS+5µg/mL Puromycin |
| Selection Marker | Puromycin |
| Morphology | Epithelial-like |
| Subculture | Split at a ratio of 1:4–1:6 every 2–3 days |
| Incubation | 37°C with 5% CO₂ |
| Storage | Liquid nitrogen immediately upon receiving |
| Doubling Time | Estimated 36 hours |
| Mycoplasma Status | Negative |
| In Vivo Validation | NA |